Gold Analisa Diagnostica Ltda

What Gold Analisa Diagnostica Ltda does

Gold Analisa Diagnostica Ltda is a privately held Brazilian manufacturer of in vitro diagnostic (IVD) reagents and semi-automated clinical analyzers, headquartered in Belo Horizonte, Minas Gerais. The company was founded in 1983 (per firmographic records) and operates with 11-50 employees, holding ANVISA Good Manufacturing Practices certification and ISO 9001:2015 quality management certification. Its portfolio spans clinical biochemistry (liquid-stable reagents for enzymes, substrates, lipids, proteins, and electrolytes), coagulation, hematology (reagents compatible with Abbott, Sysmex, Siemens, Mindray, Coulter, and Horiba analyzers), immunohematology, immunology, latex agglutination, turbidimetry, urinalysis, and rapid immunochromatographic tests (including COVID-19, Dengue, HIV, Troponin I). Proprietary equipment includes the CLOT 2 two-channel semi-automatic coagulometer (mechanical detection via electromagnetic spheres), the BIO 150 and BIO 300 biochemistry analyzers, the FIA 100 and FIA 600 fluorescence immunoassay analyzers, the HB 100 hemoglobin analyzer, and the LYTE 5 electrolyte analyzer.

The company's business model centers on selling proprietary equipment paired with reagent consumables to clinical laboratories across Brazil, primarily through a direct B2B sales team supplemented by accredited distributors. Pricing is quote-based and not publicly disclosed. Commercial activity includes participation in the SBAC (Sociedade Brasileira de Análises Clínicas) Congress, technical-scientific publications, and multi-channel customer contact (phone, WhatsApp, email). Gold Analisa is positioned as a domestic Brazilian manufacturer with no disclosed parent company, institutional investors, M&A activity, or international expansion, and operates a horizontal segmentation strategy targeting small-to-medium clinical laboratories that need reliable, stable reagents and accessible automated equipment.

Its competitive positioning relies on regulatory compliance (ANVISA BPF, ISO 9001:2015), product breadth across multiple IVD disciplines, ongoing formulation improvements, and a long operating history. No funding rounds, venture capital backing, named enterprise customers, public revenue figures, or international operations have been disclosed in the available source material.

Name

Gold Analisa Diagnostica Ltda

Legal name

Gold Analisa Diagnóstica Ltda.

Website

https://goldanalisa.com.br

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Short description

Gold Analisa Diagnostica Ltda is a Brazilian manufacturer (founded 1983, Belo Horizonte) of in vitro diagnostic reagents and semi-automated clinical analyzers, serving clinical laboratories across Brazil through direct sales and accredited distributors under ANVISA GMP and ISO 9001:2015 certifications.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostic Reagents and Clinical Analyzers

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Hematology & Coagulation Diagnostics (HLAHAAAB)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

Keywords

• In vitro diagnostics
• Clinical chemistry reagents
• Coagulation analyzers
• Rapid diagnostic tests
• Hematology reagents

Headquarters

HQ city

Belo Horizonte

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Reagents and Equipment Sales: Sale of in vitro diagnostic reagents for clinical biochemistry, coagulation, immunology, hematology, urinalysis and other clinical laboratory tests. Also includes sale of diagnostic equipment including coagulometers, biochemistry analyzers, and rapid testing devices.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Gold Analisa develops, manufactures, and sells in vitro diagnostic reagents and semi-automatic clinical analyzers for clinical laboratories in Brazil. The portfolio spans liquid stable biochemistry reagents, coagulation reagents and the CLOT 2 coagulometer, hematology reagents for major analyzer brands, immunohematology blood typing products, turbidimetric protein assays, latex agglutination tests, immunology reagents, urinalysis strips, and FIA POCT rapid immunochromatographic tests. All manufacturing is performed under ANVISA Good Manufacturing Practices and ISO 9001:2015 certification at the company's headquarters in Belo Horizonte.

Product overview

Gold Analisa Diagnóstica produces in vitro diagnostic products primarily in clinical biochemistry (liquid stable reagents), coagulation, hematology, immunohematology, immunology, rapid tests, turbidimetry, and urinalysis. The product portfolio includes semiautomated analyzers (CLOT 2 coagulation analyzer, BIO 150/300 biochemistry analyzers, FIA 100/600 immunoassay analyzers, HB 100 hemoglobin analyzer, LYTE 5 electrolyte analyzer),配套 reagent lines covering clinical chemistry tests (enzymes, substrates, lipids, proteins), coagulation assays (TP, TTPA, Fibrinogen), FIA POCT rapid tests (cardiac markers, hormones, infectious diseases), hematology reagents for major analyzer brands, immunohematology blood typing products, turbidimetric protein assays, latex agglutination tests, and urinalysis strips. The company operates under ANVISA Good Manufacturing Practice and ISO 9001:2015 certifications.

Differentiator

Problem solved

Functional benefit

Products and services

• CLOT 2 Semi-Automatic Coagulometer Two-channel semi-automatic coagulation analyzer with electromagnetic sphere mechanical measurement system for detecting clot formation, featuring calibration curve storage, four independent timers, five reagent incubators at 37°C, eight incubation positions, open system, thermal printer, and INR calculation capability. Intended for clinical laboratories performing coagulation testing.
• BIO 150 Biochemistry Analyzer Biochemistry analyzer designed for clinical laboratory diagnostic use as part of Gold Analisa's equipment lineup.
• BIO 300 Biochemistry Analyzer
• FIA 100 Fluorescence Immunoassay Analyzer
• FIA 600 Fluorescence Immunoassay Analyzer
• HB 100 Hemoglobin Analyzer
• LYTE 5 Electrolyte Analyzer
• Biochemistry Reagents
• TP Líquida (Liquid Prothrombin Time)
• TTPA Líquida (Liquid aPTT)
• Fibrinogênio (Fibrinogen) Reagent
• FIA POCT Rapid Testing Solutions
• Rapid Diagnostic Tests
• Hematology Reagents
• Immunohematology Products
• Turbidimetry Products
• Urinalysis Products
• Latex Agglutination Products
• Immunology Products
• Anticoagulants
• Coagulation Quality Controls

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• Labtest Diagnóstica: Brazilian IVD reagents and equipment manufacturer headquartered in Lagoa Santa, MG, producing biochemistry, hematology, immunology, and rapid test kits for clinical laboratories — closely comparable in product mix, geographic focus, and B2B lab-channel GTM.
• Wama Diagnóstica: Brazilian IVD manufacturer producing diagnostic kits and reagents for clinical laboratories across multiple disciplines including immunohematology, parasitology, and urinalysis — comparable domestic competitor with similar product breadth.
• Bioclin / Quibasa: Brazilian manufacturer (Quibasa Química Básica) of in vitro diagnostic reagents including biochemistry, immunology, and rapid tests for clinical labs and blood banks, directly overlapping with Gold Analisa's domestic reagent portfolio and Brazilian customer base.
• RenyLab / RMD Diagnosis: Brazilian manufacturer of in vitro diagnostic reagents (biochemistry, hematology, immunology, urinalysis) with comparable B2B clinical lab go-to-market and similar scale in the Brazilian IVD space.
• Ebram Produtos para Laboratórios: Brazilian IVD company producing clinical chemistry, immunoassay, hematology, and rapid diagnostic reagents for the Brazilian clinical laboratory market, with overlapping customer base and similar domestic-manufacturing positioning.

Emerging players

• Mindray Bio-Medical: Chinese-based emerging IVD and hematology equipment player whose analyzers are among those listed as compatible with Gold Analisa's hematology reagents; competes on cost-effective chemistry and hematology systems in emerging markets including Latin America.

Broad incumbents

• Sysmex Corporation: Global hematology and coagulation diagnostics leader whose automated analyzers are explicitly supported by Gold Analisa's hematology reagent line — both as a reagent partner and a competing equipment/reagent supplier in Brazilian hematology labs.
• Abbott Diagnostics: Multinational IVD and point-of-care leader (Architect, Alinity ci-series, i-STAT) competing with Gold Analisa across biochemistry, immunoassay, and rapid testing segments in Brazil.
• Roche Diagnostics (Brasil): Global IVD giant operating in Brazil through cobas automated chemistry, immunoassay, and coagulation platforms serving hospital labs; competes with Gold Analisa on coagulation, biochemistry, and immunodiagnostics but at higher volume and price points.
• Siemens Healthineers: Multinational IVD and hematology equipment leader (Atellica, Advia Centaur, Sysmex partnership) competing with Gold Analisa on coagulation, clinical chemistry, and hematology reagents across large Brazilian hospital networks.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/goldanalisa

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gold Analisa Diagnostica Ltda